Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Virtual Colonoscopies Help Identify Additional Tumors Outside of the Colon

By MedImaging International staff writers
Posted on 14 Sep 2010
Although medical specialists has already accepted that colorectal cancer (CRC) screening is cost-effective and saves lives, investigators have found that computed tomography colonography (CTC or virtual colonoscopy) not only identifies CRC but also doubles the yield of detecting significant early extracolonic lesions, resulting in lives saved.

CTC is an emerging noninvasive rapid imaging technique developed for CRC screening. It is less invasive than optical colonoscopy and may improve patient adherence and CRC screening. In addition to intracolonic findings, CTC examines the entire abdomen and pelvis similarly to a CT scan. "The ability of CTC to identify significant extracolonic lesions at an early treatable stage may increase the yield of CRC screening, thus enhancing CTC as a major screening technique,” said Ganesh R. Veerappan, M.D., lead author of the study, published in the September 2010 issue of the American Journal of Roentgenology (AJR).

The study, performed at Walter Reed Army Medical Center (Washington, DC, USA) included 2,277 patients who underwent CTC. Of those patients, extracolonic findings were identified in 1,037 patients, with 787 insignificant and 240 significant findings. "When considering extracolonic findings, CTC increased the odds of identifying high-risk lesions by 78%. CTC should be considered as an alternative to optimal colonoscopy for colorectal cancer screening or as a onetime procedure to identify significant treatable intracolonic and extracolonic lesions,” concluded Dr. Veerappan.

Related Links:
Walter Reed Army Medical Center


Multi-Use Ultrasound Table
Clinton
Mammo DR Retrofit Solution
DR Retrofit Mammography
Adjustable Mobile Barrier
M-458
Mammography System (Analog)
MAM VENUS

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.